National Health Investors, Inc. (NHI)
National Health Investors: This 5.7% Healthcare REIT Is A Hold
National Health Investors is rated 'Hold' as portfolio shifts and recent asset sales pressure near-term earnings and dividend growth. NHI's SHOP segment expansion is a key strategic focus, but same-store NOI declined, raising concerns about execution as SHOP grows to 40–50% of the portfolio. Following the $560M NHC sale, NHI's balance sheet is robust with pro forma net debt/EBITDA at 2.5x and no significant maturities until 2028.
National Health Investors Q2 Earnings Call Highlights
National Health Investors NYSE: NHI reported second-quarter results that management said were in line with expectations, alongside the completion of a major portfolio sale and continued expansion of its seniors housing operating portfolio, or SHOP.
National Health Investors, Inc. (NHI) Q2 2026 Earnings Call Transcript
National Health Investors, Inc. (NHI) Q2 2026 Earnings Call Transcript
National Health Investors (NHI) Q2 FFO Lag Estimates
National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.19 per share, missing the Zacks Consensus Estimate of $1.26 per share. This compares to FFO of $1.22 per share a year ago.
National Health Investors: The Silver Tsunami Makes This REIT Undervalued
National Health Investors, Inc. remains a Buy, supported by strong financials, an attractive valuation, and a sustainable ~5% dividend yield. NHI's $560M asset sale and $107M SHOP investment accelerate its transition to the Senior Housing Operating Portfolio model, enhancing growth potential. Pro forma net debt/EBITDA expected at 2.3x following NHI's major sale and a ~74.5% FAD payout ratio based on guidance highlight NHI's balance sheet strength and dividend flexibility.
National Health Investors: An Investment-Grade Healthcare REIT With Portfolio Growth And More
National Health Investors is rated a buy, driven by robust macro demand for senior care, portfolio expansion, and a compelling 5% dividend yield. NHI demonstrates strong top-line growth, geographic diversity, and resilient 5-year revenue trends, with recent acquisitions further solidifying its market presence. Despite modest FFO growth expectations and technical bearishness, NHI benefits from an investment-grade Fitch rating, prudent leverage, and strong ROE among peers.
Implied Volatility Surging for National Health Investors Stock Options
Investors need to pay close attention to NHI stock based on the movements in the options market lately.
National Health Investors, Inc. (NHI) Q1 2026 Earnings Call Transcript
National Health Investors, Inc. (NHI) Q1 2026 Earnings Call Transcript
National Health Investors (NHI) Q1 FFO and Revenues Beat Estimates
National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.24 per share, beating the Zacks Consensus Estimate of $1.21 per share. This compares to FFO of $1.15 per share a year ago.
DOC or NHI: Which Is the Better Value Stock Right Now?
Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both Healthpeak (DOC) and National Health Investors (NHI). But which of these two stocks is more attractive to value investors?
National Health Investors: Get Paid As Senior Housing Growth Accelerates
National Health Investors is a healthcare REIT focused on senior housing and skilled nursing, offering both income and growth potential. NHI's FFO per share grew 10.6% in 2025, driven by SHOP platform expansion and stable triple-net lease performance. The current 4.5% dividend yield is well-covered, with resumed growth and a conservative 74% payout ratio, supported by a strong BBB- balance sheet.
National Health Investors, Inc. (NHI) Q4 2025 Earnings Call Transcript
National Health Investors, Inc. (NHI) Q4 2025 Earnings Call Transcript
